Surgical Management of Primary Cardiac Tumor: Early and Late Results.
- Author:
Joon Kyu KANG
1
;
Yu Sang YOON
;
Hyung Tae KIM
;
Cheol Joo LEE
;
In Duk PARK
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Ajou University Hospital, Korea. cjlee@ajou.ac.kr
- Publication Type:Original Article
- Keywords:
Heart neoplasms;
Neoplasm outcomes
- MeSH:
Female;
Follow-Up Studies;
Heart Neoplasms*;
Hemangioma;
Hemangiosarcoma;
Humans;
Male;
Mesothelioma;
Mortality;
Myxoma;
Pathology;
Prognosis;
Rare Diseases;
Retrospective Studies
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2004;37(3):228-234
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Primary cardiac tumors are rare disease and they present nonspecific symptom. They are divided in benign and malignant tumors and require surgical therapy and/or additional therapy. MATERIAL AND METHOD: From March 1995 to March 2003, twenty one patients were diagnosed as having primary cardiac tumors. We analysed them retrospectively in terms of various perioperative factors and early and late results. RESULT: 6 men and 15 women and their average age was 45.44+/-18.76. Pathology revealed eighteen benign (fourteen myxoma, two fibroelastoma, one hemangioma and one paraganglioma) disease and three malignant (one angiosarcoma, one mesothelioma and one myxofibrosarcoma) disease. There was one (myxoma) operative mortality and three late death (hemangioma, angiosarcoma and mesothelioma) during additional therapy and follow up. CONCLUSION: Surgical treatment of primary cardiac tumor is important and sometimes additional therapy is required but the prognosis of malignant cardiac tumor is still very poor.
